Crux Biomedical Inc., a Portola Valley, Calif.-based medical device startup from former NeoPath and Bacchus Vascular executive Mel Schatz, has raised around $3.85 million in Series A funding, according to a regulatory filing cited by PE Week. Backers include Alloy Ventures and Dr. Thomas Fogerty.
Update: We see that SiliconTap had the news first.
VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Learn more about membership.